BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3035522)

  • 21. Utility of 123C3 monoclonal antibody against CD56 (NCAM) for the diagnosis of small cell carcinomas on paraffin sections.
    Kaufmann O; Georgi T; Dietel M
    Hum Pathol; 1997 Dec; 28(12):1373-8. PubMed ID: 9416693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung.
    Upton MP; Hirohashi S; Tome Y; Miyazawa N; Suemasu K; Shimosato Y
    Am J Surg Pathol; 1986 Aug; 10(8):560-7. PubMed ID: 2426981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New anti-lung-cancer antibody cluster 12 reacts with human folate receptors present on adenocarcinoma.
    Franklin WA; Waintrub M; Edwards D; Christensen K; Prendegrast P; Woods J; Bunn PA; Kolhouse JF
    Int J Cancer Suppl; 1994; 8():89-95. PubMed ID: 8194901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the antigenic determinant recognized by the monoclonal antibody 44-3A6 on select human adenocarcinomas and normal human tissues.
    Combs SG; Radosevich JA; Ma Y; Lee I; Gould VE; Battifora H; Rosen ST
    Tumour Biol; 1988; 9(2-3):116-22. PubMed ID: 2456598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KM195 as an immunohistochemical marker of adenocarcinoma of the lung.
    Kawai T; Hiroi S; Hanai N; Shitara K
    Lung Cancer; 1996 Aug; 15(1):41-50. PubMed ID: 8865122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1998 Oct; 22(10):1215-21. PubMed ID: 9777983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel monoclonal antibody-defined antigen which distinguishes human non-small cell from small cell lung carcinomas.
    Sobol RE; Peters RE; Astarita RW; Hofeditz C; Masui H; Burton D; Handley HH; Glassy MC; Fairshter R; Carlo DJ
    Cancer Res; 1986 Sep; 46(9):4746-50. PubMed ID: 3015395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokeratin and neurofilament in lung carcinomas.
    van Muijen GN; Ruiter DJ; van Leeuwen C; Prins FA; Rietsema K; Warnaar SO
    Am J Pathol; 1984 Sep; 116(3):363-9. PubMed ID: 6206727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.
    Yanagita E; Imagawa N; Ohbayashi C; Itoh T
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):509-13. PubMed ID: 21415705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. My-1, the human myeloid-specific antigen detected by mouse monoclonal antibodies, is a sugar sequence found in lacto-N-fucopentaose III.
    Huang LC; Civin CI; Magnani JL; Shaper JH; Ginsburg V
    Blood; 1983 May; 61(5):1020-3. PubMed ID: 6187397
    [No Abstract]   [Full Text] [Related]  

  • 31. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
    Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
    Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical localization of Leu-M1 carbohydrate antigen in human oral squamous cell carcinoma.
    Teng YT; Nadimi H; Toto PD
    J Oral Pathol Med; 1989 Oct; 18(9):502-5. PubMed ID: 2691649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The expression of monoclonal antibody KM-93 reactive antigen in human lung carcinoma--an immunohistochemical evaluation].
    Sasaki K; Matsumura K; Ogino T; Tsuji T; Shinozaki F; Takahashi M
    Gan No Rinsho; 1988 Jul; 34(8):965-8. PubMed ID: 2457119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of lung cancer in clinical specimens using a human monoclonal antibody HB4C5-clone 3.
    Hirose H; Sato S; Tai H; Okano H; Yasumoto K; Murakami H; Nomoto K; Matsuyama M; Tamaki S; Hashizume S
    Hum Antibodies Hybridomas; 1991 Oct; 2(4):200-6. PubMed ID: 1661189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of monoclonal antibody 44-3A6 in the cytodiagnosis and classification of pulmonary carcinomas.
    Banner BF; Gould VE; Radosevich JA; Ma Y; Lee I; Rosen ST
    Diagn Cytopathol; 1985; 1(4):300-7. PubMed ID: 3836094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human monoclonal antibody 28K29 highly reactive with lung adenocarcinomas of all grades of differentiation and with large cell carcinomas.
    Yoshinari K; Aoki T; Yamada H; Sugawara I
    Lung Cancer; 1999 Aug; 25(2):95-103. PubMed ID: 10470843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
    Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
    Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential expression of immunoreactive fucosylceramide in adenocarcinoma of the lung.
    Yamada H; Ishihara H; Kitagawa H; Kawabata Y; Itoyama S; Sugawara I
    Cancer Res; 1992 Aug; 52(16):4408-12. PubMed ID: 1322788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential usefulness of monoclonal antibodies in the determination of histologic types of lung cancer in cytologic preparations.
    Koprowska I; Zipfel SA
    Acta Cytol; 1988; 32(5):675-9. PubMed ID: 2844047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.